{"id":3514,"date":"2017-08-18T10:59:36","date_gmt":"2017-08-18T14:59:36","guid":{"rendered":"https:\/\/www.arxresearch.com\/?post_type=product&p=3514"},"modified":"2017-09-21T13:53:58","modified_gmt":"2017-09-21T17:53:58","slug":"thought-leader-compensation-spain-infectious-diseases","status":"publish","type":"product","link":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/","title":{"rendered":"Fair-Market Value Compensation Rates for Infectious Diseases KOLs – Spain"},"content":{"rendered":"

This study presents fair-market value (FMV) compensation rates for Spain KOLs – Infectious Diseases, by percentiles, with averages, for six (6) activities as well as for non-specific activities, for four (4) levels of Thought Leader influences (rare, international, national and local). Thought Leader Compensation Spain Infectious Diseases.<\/p>\n

Payments made to physicians and thought leaders have been under scrutiny for a few years and companies have been working to adjust their rates to level with industry standards. Adjustments to “market” rates should be done periodically and are best done through 3rd party research, providing a fair and balanced assessment of rates.<\/p>\n

The research findings deliver markets rates used in the conduct of exchanges with Thought Leaders from 7 life science organizations. These payment benchmarks help legal, compliance and medical affair executives refine and support the development of fee schedules that are aligned with market conditions.<\/p>\n","protected":false},"excerpt":{"rendered":"

Fair-Market Value Compensation Rates for Spain HCPs – Infectious Diseases presents hourly and half-day flat compensation rates for four (4) Thought Leader levels based on degree of influence. The analysis includes rates for six (6) specific activities as well as for other non-specified activities. The findings presented in this report result from the input from executives at 7 life science organizations. Thought Leader Compensation Spain Infectious Diseases.<\/p>\n

Number of pages: 23
\nFormat: Full Analysis, PDF
\nPublished: 2017<\/p>\n

Price: $695<\/strong><\/p>\n","protected":false},"featured_media":3491,"template":"","meta":[],"product_cat":[131],"product_tag":[155,133,134,163,135,142,139,140,218,141,138],"yoast_head":"\nThought Leader Compensation Spain Infectious Diseases (KOL-FMV)<\/title>\n<meta name=\"description\" content=\"This report presents FMV compensation rates for payments to Spain KOLs in Infectious Diseases (Thought Leader Compensation Spain Infectious Diseases).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thought Leader Compensation Spain Infectious Diseases (KOL-FMV)\" \/>\n<meta property=\"og:description\" content=\"This report presents FMV compensation rates for payments to Spain KOLs in Infectious Diseases (Thought Leader Compensation Spain Infectious Diseases).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"Arx Research\" \/>\n<meta property=\"article:modified_time\" content=\"2017-09-21T17:53:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/FMV-ES-Infect.png\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"375\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/\",\"url\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/\",\"name\":\"Thought Leader Compensation Spain Infectious Diseases (KOL-FMV)\",\"isPartOf\":{\"@id\":\"https:\/\/www.arxresearch.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/FMV-ES-Infect.png\",\"datePublished\":\"2017-08-18T14:59:36+00:00\",\"dateModified\":\"2017-09-21T17:53:58+00:00\",\"description\":\"This report presents FMV compensation rates for payments to Spain KOLs in Infectious Diseases (Thought Leader Compensation Spain Infectious Diseases).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#primaryimage\",\"url\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/FMV-ES-Infect.png\",\"contentUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/FMV-ES-Infect.png\",\"width\":500,\"height\":375,\"caption\":\"Thought Leader Compensation Spain Infectious Diseases\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arxresearch.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reports\",\"item\":\"https:\/\/www.arxresearch.com\/reports\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Fair-Market Value Compensation Rates for Infectious Diseases KOLs – Spain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arxresearch.com\/#website\",\"url\":\"https:\/\/www.arxresearch.com\/\",\"name\":\"Arx Research\",\"description\":\"Medical Affairs Benchmarking\",\"publisher\":{\"@id\":\"https:\/\/www.arxresearch.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arxresearch.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arxresearch.com\/#organization\",\"name\":\"Arx Research\",\"url\":\"https:\/\/www.arxresearch.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png\",\"contentUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png\",\"width\":217,\"height\":100,\"caption\":\"Arx Research\"},\"image\":{\"@id\":\"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/arx-research\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thought Leader Compensation Spain Infectious Diseases (KOL-FMV)","description":"This report presents FMV compensation rates for payments to Spain KOLs in Infectious Diseases (Thought Leader Compensation Spain Infectious Diseases).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/","og_locale":"en_US","og_type":"article","og_title":"Thought Leader Compensation Spain Infectious Diseases (KOL-FMV)","og_description":"This report presents FMV compensation rates for payments to Spain KOLs in Infectious Diseases (Thought Leader Compensation Spain Infectious Diseases).","og_url":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/","og_site_name":"Arx Research","article_modified_time":"2017-09-21T17:53:58+00:00","og_image":[{"width":500,"height":375,"url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/FMV-ES-Infect.png","type":"image\/png"}],"twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/","url":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/","name":"Thought Leader Compensation Spain Infectious Diseases (KOL-FMV)","isPartOf":{"@id":"https:\/\/www.arxresearch.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#primaryimage"},"image":{"@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/FMV-ES-Infect.png","datePublished":"2017-08-18T14:59:36+00:00","dateModified":"2017-09-21T17:53:58+00:00","description":"This report presents FMV compensation rates for payments to Spain KOLs in Infectious Diseases (Thought Leader Compensation Spain Infectious Diseases).","breadcrumb":{"@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#primaryimage","url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/FMV-ES-Infect.png","contentUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/FMV-ES-Infect.png","width":500,"height":375,"caption":"Thought Leader Compensation Spain Infectious Diseases"},{"@type":"BreadcrumbList","@id":"https:\/\/www.arxresearch.com\/reports\/thought-leader-compensation-spain-infectious-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arxresearch.com\/"},{"@type":"ListItem","position":2,"name":"Reports","item":"https:\/\/www.arxresearch.com\/reports\/"},{"@type":"ListItem","position":3,"name":"Fair-Market Value Compensation Rates for Infectious Diseases KOLs – Spain"}]},{"@type":"WebSite","@id":"https:\/\/www.arxresearch.com\/#website","url":"https:\/\/www.arxresearch.com\/","name":"Arx Research","description":"Medical Affairs Benchmarking","publisher":{"@id":"https:\/\/www.arxresearch.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arxresearch.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arxresearch.com\/#organization","name":"Arx Research","url":"https:\/\/www.arxresearch.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png","contentUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png","width":217,"height":100,"caption":"Arx Research"},"image":{"@id":"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/arx-research"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product\/3514"}],"collection":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/media\/3491"}],"wp:attachment":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/media?parent=3514"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product_cat?post=3514"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product_tag?post=3514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}